Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06238128 · ClinicalTrials.gov registry record · NA
Opioid Rapid Response System: Naloxone Training in Communities
A NA study of Opioid Overdose, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 773
- Enrollment target
- 1
- Study location
NCT06238128 is a NA study of Opioid Overdose that has completed, run by University of Missouri-Columbia. The registered enrollment target is 773 participants, below the 4,146-participant average among 8 other Opioid Overdose trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06238128, a NA study of Opioid Overdose, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 773 participants
- Enrollment target
- 1
- Study location
Study Summary
The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in geographically dispersed rural areas and densely populated urban settings. Effectively delivering the life-saving drug naloxone, which counteracts the effects of overdoses, necessitates a well-coordinated and cost-efficient response system. Simply opting for widespread distribution of naloxone, even with citizen involvement, proves to be a financially burdensome approach when compared to more targeted strategies. Moreover, obstacles such as limited access, inadequate or unavailable naloxone training, and delayed response times from emergency responders compound the problem. Addressing these issues, the proposed Opioid Rapid Response System (ORRS) project seeks to advance prevention science by adopting an innovative approach that incorporates technology and contemporary communication theory. The primary objective of the ORRS project is to mitigate opioid overdose deaths by enlisting and training citizens to administer naloxone in response to such events. Leveraging the PulsePoint health app, which connects citizens to cardiac events, the ORRS project will extend its capabilities to respond to overdose incidents. This initiative involves comprehensive development of ORRS, followed by a randomized clinical trial on a national scale to assess its effectiveness. The study aims to contribute to both prevention and implementation science by identifying optimal recruitment strategies and testing a model of online training. In pursuit of these objectives, the study is guided by the following Specific Aims: SA 1: Refine and complete the development of ORRS. SA 2: Conduct a randomized clinical trial to evaluate the effectiveness of the intervention. SA 3: Prepare ORRS for dissemi
Conditions Studied
Interventions
- BEHAVIORAL Opioid Rapid Resonse System (ORRS) training
- BEHAVIORAL Non-active opioid overdose response training
Study Locations (1)
California
- Ewald & Wasserman Research Consultants, LLC - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 773 participants |
| Start Date | 2024-05-24 |
| Est. Completion | 2025-12-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06238128
The ClinicalTrials.gov registry entry for NCT06238128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 773 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,146-participant average among 8 other Opioid Overdose trials with a reported enrollment target (81% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Opioid Overdose appearing as the primary indexed condition, and to 2 interventions - of which Opioid Rapid Resonse System (ORRS) training is the first listed.
NCT06238128 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06238128 about?
NCT06238128 is a clinical study titled "Opioid Rapid Response System: Naloxone Training in Communities". The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in ...
What is the current status of trial NCT06238128?
This trial is currently completed. It is a NA study. The enrollment target is 773 participants. The study started on 2024-05-24. Estimated completion is 2025-12-29.
What conditions does trial NCT06238128 study?
This clinical trial studies the following conditions: Opioid Overdose.
What interventions are being tested in trial NCT06238128?
The interventions under investigation include: Opioid Rapid Resonse System (ORRS) training (BEHAVIORAL), Non-active opioid overdose response training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06238128?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06238128 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Overdose
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Availability of Intranasal Naloxone
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
A Bundled Intervention
RECRUITING · Phase 1
-
Quantitative Xylazine Measurement in ED
RECRUITING
-
Vending Machine Naloxone Distribution for Your Community (VENDY)
RECRUITING · Phase 4
-
Young Houston Emergency Opioid Engagement System
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.